rs200830807

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_001943.5(DSG2):​c.3040G>A​(p.Val1014Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

DSG2
NM_001943.5 missense

Scores

2
5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:1

Conservation

PhyloP100: 3.50
Variant links:
Genes affected
DSG2 (HGNC:3049): (desmoglein 2) This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]
DSG2-AS1 (HGNC:51311): (DSG2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High AC in GnomAd4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSG2NM_001943.5 linkc.3040G>A p.Val1014Ile missense_variant Exon 15 of 15 ENST00000261590.13 NP_001934.2 Q14126
DSG2XM_047437315.1 linkc.2506G>A p.Val836Ile missense_variant Exon 16 of 16 XP_047293271.1
DSG2-AS1NR_045216.1 linkn.1346-520C>T intron_variant Intron 3 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSG2ENST00000261590.13 linkc.3040G>A p.Val1014Ile missense_variant Exon 15 of 15 1 NM_001943.5 ENSP00000261590.8 Q14126
DSG2-AS1ENST00000583706.5 linkn.1384-520C>T intron_variant Intron 3 of 5 5
DSG2-AS1ENST00000657343.1 linkn.697-520C>T intron_variant Intron 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000722
AC:
18
AN:
249392
Hom.:
0
AF XY:
0.0000665
AC XY:
9
AN XY:
135296
show subpopulations
Gnomad AFR exome
AF:
0.000129
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.0000556
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000175
AC:
256
AN:
1461870
Hom.:
0
Cov.:
32
AF XY:
0.000169
AC XY:
123
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000176
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000217
Gnomad4 OTH exome
AF:
0.0000828
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152198
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74360
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000115
Hom.:
0
Bravo
AF:
0.000132
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000359
AC:
3
ExAC
AF:
0.0000496
AC:
6
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:8Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:2
Apr 10, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: DSG2 c.3040G>A (p.Val1014Ile) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 249792 control chromosomes. The observed variant frequency is approximately 7.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSG2 (1e-05), strongly suggesting that the variant is benign. c.3040G>A has been reported in the literature as a VUS in settings of multigene panel testing of individuals with a variety of cardiac phenotypes such as idiopathic dilated cardiomyopathy (DCM), DCM, exertion-related sudden unexplained death in the young (SUDY) (example, Elliott_2010, Pugh_2014, Anderson_2016, Mellor_2017, Walsh_2017) and as a Likely Pathogenic cardiomyopathy associated variant in at-least one individual with hypertension/stroke (example, Ng_2013). These data do not allow any conclusion about variant significance. At-least one of these reports mentions a co-occurrence with another pathogenic variant in an individual with exertion-related sudden unexplained death in the young (SUDY) (MYBPC3 c.2374T>C, p.Trp792Arg), providing supporting evidence for a benign role (Anderson_2016). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS, n=5; Likely benign, n=1). Some submitters cite overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -

Jul 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The Val1014Ile variant in DSG2 has been reported in 1 individual with DCM and wa s absent from 400 control chromosomes (Elliott 2010). In addition, this variant has been identified in 3/8352 European American chromosomes from a broad populat ion by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). C omputational analyses (biochemical amino acid properties, conservation, AlignGVG D, PolyPhen2, and SIFT) do not provide strong support for or against an impact t o the protein. Additional information is needed to fully assess the clinical sig nificance of the Val1014Ile variant. -

Cardiomyopathy Uncertain:2
Mar 16, 2023
Color Diagnostics, LLC DBA Color Health
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This missense variant replaces valine with isoleucine at codon 1014 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been identified in three individuals affected with dilated cardiomyopathy (PMID: 20716751, 23861362, 24503780). This variant has been observed in a young individual with exertion-induced sudden unexplained death, who also carried a pathogenic variant in the MYBPC3 gene (PMID: 27114410). This variant has also been identified in 19/280798 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Dec 18, 2015
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Jan 11, 2024
All of Us Research Program, National Institutes of Health
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This missense variant replaces valine with isoleucine at codon 1014 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been identified in three individuals affected with dilated cardiomyopathy (PMID: 20716751, 23861362, 24503780). This variant has been observed in a young individual with exertion-induced sudden unexplained death, who also carried a pathogenic variant in the MYBPC3 gene (PMID: 27114410). This variant has also been identified in 19/280798 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Arrhythmogenic right ventricular dysplasia 10 Uncertain:1
Jan 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 1014 of the DSG2 protein (p.Val1014Ile). This variant is present in population databases (rs200830807, gnomAD 0.01%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 20716751, 23861362, 24503780, 27532257). ClinVar contains an entry for this variant (Variation ID: 44309). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DSG2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Primary dilated cardiomyopathy Uncertain:1
Apr 05, 2018
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: research

- -

Cardiovascular phenotype Uncertain:1
Mar 25, 2020
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.3040G>A (p.V1014I) alteration is located in exon 15 (coding exon 15) of the DSG2 gene. This alteration results from a G to A substitution at nucleotide position 3040, causing the valine (V) at amino acid position 1014 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Mar 26, 2025
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.61
T
M_CAP
Benign
0.073
D
MetaRNN
Uncertain
0.73
D
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Pathogenic
3.0
M
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.52
N
REVEL
Uncertain
0.30
Sift
Benign
0.045
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.80
P
Vest4
0.68
MVP
0.73
MPC
0.24
ClinPred
0.11
T
GERP RS
4.3
Varity_R
0.034
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200830807; hg19: chr18-29126389; API